Skip to Main Content

Author Details

Michael P Curry
Beth Israel Deaconess Medical Center, Harvard Medical School
1997
139
39
PMIDPaper TitleJournal TitlePublished Year
37638802Angiography with cone-beam CT versus contrast-enhanced MRI for living donor transplant imaging: Is MRI enough?Clin Anat2024
36662395Pregnancy-associated breast cancer: does timing of presentation affect outcome?Breast Cancer Res Treat2023
37182668Transjugular Intrahepatic Portosystemic Shunt and Thrombectomy (TIPS-Thrombectomy) for Symptomatic Acute Noncirrhotic Portal Vein Thrombosis.J Vasc Interv Radiol2023
37380291Prognostic Models in Acute-on-Chronic Liver Failure.Clin Liver Dis2023
37143199The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.Kidney3602023
36521795Technical Feasibility of Suction Thrombectomy Using a Large-Bore Aspiration System in the Portomesenteric Venous System.J Vasc Interv Radiol2023
36882138Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c.Ann Hepatol2023
36475810Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database.AJR Am J Roentgenol2023
36738082Liver transplantation in alcohol-associated liver disease: ensuring equity through new processes.Liver Transpl2023
36633470Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.Hepatol Commun2023
34662439Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.Hepatology2022
35667277Willingness of Kidney and Liver Transplant Candidates to Receive HCV-Infected Organs.J Surg Res2022
35445803First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide.Hepatol Commun2022
36304492Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades.J Clin Transl Hepatol2022
35170360Echocardiographic and Other Preprocedural Predictors of Heart Failure After TIPS Placement in Patients With Cirrhosis: A Single-Center 15-Year Analysis.AJR Am J Roentgenol2022
34792136Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.J Infect Dis2022
34808392Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant - A retrospective cohort analysis.Ann Hepatol2022
32901301Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.Eur Radiol2021
33657294Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.N Engl J Med2021
33647502The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population.Ann Hepatol2021
33845172Reply to: The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population.Ann Hepatol2021
34646998Reduced steatosis and weight as a result of specific diets or the dietitian themselves.JHEP Rep2021
34454031Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.J Vasc Interv Radiol2021
34105360Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.J Manag Care Spec Pharm2021
34231523Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation.Eur J Gastroenterol Hepatol2021
33164276Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis.Liver Transpl2021
31126651Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients.J Thorac Cardiovasc Surg2020
32061651Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis.J Hepatol2020
32279176Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection.Adv Ther2020
32173967Over 2 Decades of Transplanting Hepatitis C Virus-Positive Liver Allografts: Almost Full Circle With Encouraging Early Results.Liver Transpl2020
30959554Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C.Liver Int2019
31750374Budd-Chiari Syndrome in a Patient With Simultaneous Diagnosis of Hepatic Sarcoidosis and Nodular Regenerative Hyperplasia.ACG Case Rep J2019
31389265The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding.Expert Rev Gastroenterol Hepatol2019
31584469Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized Approach.Cardiol Rev2019
31318504Changing demographics among populations prescribed HCV treatment, 2013-2017.Am J Manag Care2019
31445380Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study.J Neuroimmunol2019
30809932Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients.Liver Int2019
28681542Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States.Hepatology2018
29859740Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1.Lancet Gastroenterol Hepatol2018
30359488Primary Stent Placement for Hepatic Artery Stenosis After Liver Transplantation: Improving Primary Patency and Reintervention Rates.Liver Transpl2018
29665097Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.Aliment Pharmacol Ther2018
29439971Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus.Antimicrob Agents Chemother2018
29535028Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.Gastroenterology2018
29430469Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient.ACG Case Rep J2018
28837249Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage.Liver Int2018
27495755The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis.Transplantation2017
28437388International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.Transplantation2017
28437387International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.Transplantation2017
28437385Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.Transplantation2017
28249809Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies.Clin Gastroenterol Hepatol2017
  • 1 - 50 of 139

Recommended Authors

Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2017
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2014
Number of shared co-authors 1
Western University
Career Start Year 2011
Number of shared co-authors 2
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 1
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 3
David Geffen School of Medicine , University of California los angeles
Career Start Year 2006
Number of shared co-authors 0
University of Cambridge
Career Start Year 2006
Number of shared co-authors 0
Cumming School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Humanitas University
Career Start Year 2003
Number of shared co-authors 0
University of Maryland School of Medicine
Career Start Year 2002
Number of shared co-authors 2
University of Toronto
Career Start Year 2001
Number of shared co-authors 4
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 1
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 2
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
University of Virginia Health System
Career Start Year 1999
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 4
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 1
David Geffen School of Medicine , University of California los angeles
Career Start Year 1997
Number of shared co-authors 4
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 3
Corporal Michael J Crescenz VA Medical Center
Career Start Year 1996
Number of shared co-authors 3
Ajou University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
University of Queensland
Career Start Year 1993
Number of shared co-authors 2
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 1
University of Tennessee Health Science Center
Career Start Year 1991
Number of shared co-authors 2
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
University of Washington
Career Start Year 1989
Number of shared co-authors 1
Scripps Clinic and Scripps Translational Science Institute
Career Start Year 1982
Number of shared co-authors 4

Collaborators

Massachusetts General Hospital and Harvard Medical School
Co-authored papers 6
John Hunter Children's Hospital
Co-authored papers 3
Ben Gurion University
Co-authored papers 3
Virginia Commonwealth University
Co-authored papers 3
Beth Israel Deaconess Medical Center
Co-authored papers 3
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
Feinberg School of Medicine, Northwestern University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
University of Michigan School of Medicine ann arbor
Co-authored papers 1
University Clinic for Visceral Surgery and Medicine, Bern University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Miami, Miller School of Medicine
Co-authored papers 1
Center for Liver Diseases, Inova Fairfax Hospital
Co-authored papers 1
University of Sheffield and Sheffield Teaching Hospitals
Co-authored papers 1
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Intermountain Medical Center
Co-authored papers 1
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Beth Israel Deaconess Medical Center
Co-authored papers 1
King Faisal Specialist Hospital & Research Centre
Co-authored papers 1